Poster: HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety in an Open-Label, Multicenter, Phase 2 Study of Patients With Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL)
作者
Carmelo Carlo‐Stella,Stephen M. Ansell,Pier Luigi Zinzani,John Radford,Kami J. Maddocks,António Pinto,Graham P. Collins,Veronika Bachanová,Nancy L. Bartlett,Isabelle Bence‐Bruckler,Mehdi Hamadani,Justin Kline,Jiřı́ Mayer,Kerry J. Savage,Ranjana H. Advani,Paolo F. Caimi,Olivier Casasnovas,Tatyana Feldman,Brian Hess,Mariana Bastos‐Oreiro